Correlation Between Relay Therapeutics and ProKidney Corp
Can any of the company-specific risk be diversified away by investing in both Relay Therapeutics and ProKidney Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Relay Therapeutics and ProKidney Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Relay Therapeutics and ProKidney Corp, you can compare the effects of market volatilities on Relay Therapeutics and ProKidney Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Relay Therapeutics with a short position of ProKidney Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Relay Therapeutics and ProKidney Corp.
Diversification Opportunities for Relay Therapeutics and ProKidney Corp
0.05 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Relay and ProKidney is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Relay Therapeutics and ProKidney Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProKidney Corp and Relay Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Relay Therapeutics are associated (or correlated) with ProKidney Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProKidney Corp has no effect on the direction of Relay Therapeutics i.e., Relay Therapeutics and ProKidney Corp go up and down completely randomly.
Pair Corralation between Relay Therapeutics and ProKidney Corp
Given the investment horizon of 90 days Relay Therapeutics is expected to under-perform the ProKidney Corp. But the stock apears to be less risky and, when comparing its historical volatility, Relay Therapeutics is 1.43 times less risky than ProKidney Corp. The stock trades about -0.01 of its potential returns per unit of risk. The ProKidney Corp is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 209.00 in ProKidney Corp on October 12, 2024 and sell it today you would lose (51.00) from holding ProKidney Corp or give up 24.4% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 99.47% |
Values | Daily Returns |
Relay Therapeutics vs. ProKidney Corp
Performance |
Timeline |
Relay Therapeutics |
ProKidney Corp |
Relay Therapeutics and ProKidney Corp Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Relay Therapeutics and ProKidney Corp
The main advantage of trading using opposite Relay Therapeutics and ProKidney Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Relay Therapeutics position performs unexpectedly, ProKidney Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProKidney Corp will offset losses from the drop in ProKidney Corp's long position.Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
ProKidney Corp vs. Relay Therapeutics | ProKidney Corp vs. Stoke Therapeutics | ProKidney Corp vs. Pliant Therapeutics | ProKidney Corp vs. Black Diamond Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |